The cost of dasatinib can vary depending on factors such as dosage, quantity, and pharmacy. The average retail price for a 30-day supply of dasatinib 100mg tablets can range from $5,000 to over $7,000 [1].
How can I find a lower price for dasatinib?
Several options may help reduce the cost of dasatinib. Patients can explore manufacturer-sponsored patient assistance programs, which may offer discounts or free medication to eligible individuals [1]. Additionally, comparing prices at different pharmacies, including those offering mail-order services, can lead to savings [1]. Some individuals may also find lower costs through discount cards or coupons available from pharmaceutical companies or third-party providers [1].
What is the typical cash price for dasatinib?
The cash price for dasatinib is generally high, reflecting its status as a specialty medication. For example, a 30-day supply of 100mg tablets might cost around $6,000 without insurance, though this figure can fluctuate [1].
Are there discount programs available for dasatinib?
Yes, manufacturer-sponsored patient assistance programs are often available for dasatinib. These programs are designed to make the medication more accessible to those who meet specific financial and eligibility criteria [1]. Information on these programs can typically be found on the pharmaceutical manufacturer's website or by speaking with a healthcare provider or pharmacist.
How does insurance affect the cost of dasatinib?
Insurance coverage significantly impacts the out-of-pocket cost of dasatinib. While insurance plans may cover a portion of the drug's cost, patients often still face co-pays, deductibles, and co-insurance. The specific amount will depend on the individual's insurance plan benefits [1]. Some insurance plans may also have prior authorization requirements or formulary restrictions that affect which drugs are covered and at what cost.
When does the patent for dasatinib expire?
The patent protection for dasatinib is a critical factor in its pricing and the potential for generic alternatives. While specific patent expiry dates can be complex due to various patents covering different aspects of the drug, the primary patents have been expiring or are nearing expiration in many regions [2]. For detailed information on dasatinib's patent status, DrugPatentWatch.com is a valuable resource [2].
Are there generic versions of dasatinib available?
As primary patents expire, generic versions of dasatinib become eligible for market entry. The availability of generics can lead to a significant reduction in the drug's cost [2]. The exact timeline for generic availability can vary by country and can be influenced by regulatory approvals and any ongoing patent litigation.
What are the brand names for dasatinib?
Dasatinib is most commonly known by its brand name, Sprycel [1].
What is dasatinib used to treat?
Dasatinib is a tyrosine kinase inhibitor used in the treatment of chronic myeloid leukemia (CML) and Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL) [3].
What are the common side effects of dasatinib?
Common side effects associated with dasatinib include diarrhea, nausea, vomiting, rash, headache, fatigue, muscle pain, abdominal pain, and low blood cell counts (anemia, thrombocytopenia, neutropenia) [3]. More serious side effects can also occur, requiring medical attention [3].
How does dasatinib work?
Dasatinib works by inhibiting specific tyrosine kinases, which are enzymes that play a role in cancer cell growth and proliferation [3]. By blocking these enzymes, dasatinib helps to control the growth of leukemia cells.
Sources:
[1] https://www.goodrx.com/dasatinib
[2] https://drugpatentwatch.com/drugs/dasatinib
[3] https://www.cancer.gov/drug-dictionary/drug/dasatinib